Tenofovir and Entecavir Are the Most Effective Antiviral Agents for Chronic Hepatitis B: A Systematic Review and Bayesian Meta-analyses
- 1 October 2010
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 139 (4) , 1218-1229.e5
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- EASL Clinical Practice Guidelines: Management of chronic hepatitis BJournal of Hepatology, 2009
- Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis BHepatology, 2008
- Entecavir therapy for lamivudine‐refractory chronic hepatitis BHepatology, 2008
- Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patientsHepatology, 2007
- Pegylated Interferon Alfa-2b Monotherapy and Pegylated Interferon Alfa-2b plus Lamivudine Combination Therapy for Patients with Hepatitis B Virus E Antigen-Negative Chronic Hepatitis BAntimicrobial Agents and Chemotherapy, 2007
- A 1-Year Trial of Telbivudine, Lamivudine, and the Combination in Patients With Hepatitis B e Antigen—Positive Chronic Hepatitis BGastroenterology, 2005
- Epidemiology and Natural History of Hepatitis BSeminars in Liver Disease, 2005
- Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis BNew England Journal of Medicine, 2004
- Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infectionHepatology, 2002
- Lamivudine as Initial Treatment for Chronic Hepatitis B in the United StatesNew England Journal of Medicine, 1999